178 related articles for article (PubMed ID: 29717485)
1. Prospective metabolomics study identifies potential novel blood metabolites associated with pancreatic cancer risk.
Shu X; Zheng W; Yu D; Li HL; Lan Q; Yang G; Cai H; Ma X; Rothman N; Gao YT; Jia W; Xiang YB; Shu XO
Int J Cancer; 2018 Nov; 143(9):2161-2167. PubMed ID: 29717485
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of blood metabolites associated with colorectal cancer risk.
Shu X; Xiang YB; Rothman N; Yu D; Li HL; Yang G; Cai H; Ma X; Lan Q; Gao YT; Jia W; Shu XO; Zheng W
Int J Cancer; 2018 Aug; 143(3):527-534. PubMed ID: 29479691
[TBL] [Abstract][Full Text] [Related]
3. Identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the Northern Sweden Health and Disease Study.
Röhnisch HE; Kyrø C; Olsen A; Thysell E; Hallmans G; Moazzami AA
BMC Med; 2020 Jul; 18(1):187. PubMed ID: 32698845
[TBL] [Abstract][Full Text] [Related]
4. Associations between metabolites and pancreatic cancer risk in a large prospective epidemiological study.
Stolzenberg-Solomon R; Derkach A; Moore S; Weinstein SJ; Albanes D; Sampson J
Gut; 2020 Nov; 69(11):2008-2015. PubMed ID: 32060129
[TBL] [Abstract][Full Text] [Related]
5. Search for Early Pancreatic Cancer Blood Biomarkers in Five European Prospective Population Biobanks Using Metabolomics.
Fest J; Vijfhuizen LS; Goeman JJ; Veth O; Joensuu A; Perola M; Männistö S; Ness-Jensen E; Hveem K; Haller T; Tonisson N; Mikkel K; Metspalu A; van Duijn CM; Ikram A; Stricker BH; Ruiter R; van Eijck CHJ; van Ommen GB; ʼt Hoen PAC
Endocrinology; 2019 Jul; 160(7):1731-1742. PubMed ID: 31125048
[TBL] [Abstract][Full Text] [Related]
6. Identification of highly sensitive biomarkers that can aid the early detection of pancreatic cancer using GC/MS/MS-based targeted metabolomics.
Hirata Y; Kobayashi T; Nishiumi S; Yamanaka K; Nakagawa T; Fujigaki S; Iemoto T; Kobayashi M; Okusaka T; Nakamori S; Shimahara M; Ueno T; Tsuchida A; Sata N; Ioka T; Yasunami Y; Kosuge T; Kaneda T; Kato T; Yagihara K; Fujita S; Yamada T; Honda K; Azuma T; Yoshida M
Clin Chim Acta; 2017 May; 468():98-104. PubMed ID: 28215548
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics identified new biomarkers for the precise diagnosis of pancreatic cancer and associated tissue metastasis.
Luo X; Liu J; Wang H; Lu H
Pharmacol Res; 2020 Jun; 156():104805. PubMed ID: 32278036
[TBL] [Abstract][Full Text] [Related]
8. Metabolomics study reveals systematic metabolic dysregulation and early detection markers associated with incident pancreatic cancer.
Wang S; Li M; Yan L; He M; Lin H; Xu Y; Wan Q; Qin G; Chen G; Xu M; Wang G; Qin Y; Luo Z; Tang X; Wang T; Zhao Z; Xu Y; Chen Y; Huo Y; Hu R; Ye Z; Dai M; Shi L; Gao Z; Su Q; Mu Y; Zhao J; Chen L; Zeng T; Yu X; Li Q; Shen F; Chen L; Zhang Y; Wang Y; Deng H; Liu C; Wu S; Yang T; Li D; Ning G; Wu T; Wang W; Bi Y; Lu J;
Int J Cancer; 2022 Apr; 150(7):1091-1100. PubMed ID: 34792202
[TBL] [Abstract][Full Text] [Related]
9. Pre-diagnostic metabolite concentrations and prostate cancer risk in 1077 cases and 1077 matched controls in the European Prospective Investigation into Cancer and Nutrition.
Schmidt JA; Fensom GK; Rinaldi S; Scalbert A; Appleby PN; Achaintre D; Gicquiau A; Gunter MJ; Ferrari P; Kaaks R; Kühn T; Floegel A; Boeing H; Trichopoulou A; Lagiou P; Anifantis E; Agnoli C; Palli D; Trevisan M; Tumino R; Bueno-de-Mesquita HB; Agudo A; Larrañaga N; Redondo-Sánchez D; Barricarte A; Huerta JM; Quirós JR; Wareham N; Khaw KT; Perez-Cornago A; Johansson M; Cross AJ; Tsilidis KK; Riboli E; Key TJ; Travis RC
BMC Med; 2017 Jul; 15(1):122. PubMed ID: 28676103
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of serum metabolites and colorectal cancer risk.
Cross AJ; Moore SC; Boca S; Huang WY; Xiong X; Stolzenberg-Solomon R; Sinha R; Sampson JN
Cancer; 2014 Oct; 120(19):3049-57. PubMed ID: 24894841
[TBL] [Abstract][Full Text] [Related]
11. Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults.
Qiu G; Zheng Y; Wang H; Sun J; Ma H; Xiao Y; Li Y; Yuan Y; Yang H; Li X; Min X; Zhang C; Xu C; Jiang Y; Zhang X; He M; Yang M; Hu Z; Tang H; Shen H; Hu FB; Pan A; Wu T
Int J Epidemiol; 2016 Oct; 45(5):1507-1516. PubMed ID: 27694567
[TBL] [Abstract][Full Text] [Related]
12. A Prospective Investigation of Circulating Metabolome Identifies Potential Biomarkers for Gastric Cancer Risk.
Shu X; Cai H; Lan Q; Cai Q; Ji BT; Zheng W; Shu XO
Cancer Epidemiol Biomarkers Prev; 2021 Sep; 30(9):1634-1642. PubMed ID: 33795214
[TBL] [Abstract][Full Text] [Related]
13. A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women.
Jiao L; Maity S; Coarfa C; Rajapakshe K; Chen L; Jin F; Putluri V; Tinker LF; Mo Q; Chen F; Sen S; Sangi-Hyghpeykar H; El-Serag HB; Putluri N
Cancer Prev Res (Phila); 2019 Apr; 12(4):237-246. PubMed ID: 30723176
[TBL] [Abstract][Full Text] [Related]
14. Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination.
Itoi T; Sugimoto M; Umeda J; Sofuni A; Tsuchiya T; Tsuji S; Tanaka R; Tonozuka R; Honjo M; Moriyasu F; Kasuya K; Nagakawa Y; Abe Y; Takano K; Kawachi S; Shimazu M; Soga T; Tomita M; Sunamura M
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28375170
[TBL] [Abstract][Full Text] [Related]
15. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes.
He X; Zhong J; Wang S; Zhou Y; Wang L; Zhang Y; Yuan Y
Oncotarget; 2017 Apr; 8(17):29116-29124. PubMed ID: 28418859
[TBL] [Abstract][Full Text] [Related]
16. A novel serum metabolomics-based diagnostic approach to pancreatic cancer.
Kobayashi T; Nishiumi S; Ikeda A; Yoshie T; Sakai A; Matsubara A; Izumi Y; Tsumura H; Tsuda M; Nishisaki H; Hayashi N; Kawano S; Fujiwara Y; Minami H; Takenawa T; Azuma T; Yoshida M
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):571-9. PubMed ID: 23542803
[TBL] [Abstract][Full Text] [Related]
17. Prospective analysis of circulating metabolites and breast cancer in EPIC.
His M; Viallon V; Dossus L; Gicquiau A; Achaintre D; Scalbert A; Ferrari P; Romieu I; Onland-Moret NC; Weiderpass E; Dahm CC; Overvad K; Olsen A; Tjønneland A; Fournier A; Rothwell JA; Severi G; Kühn T; Fortner RT; Boeing H; Trichopoulou A; Karakatsani A; Martimianaki G; Masala G; Sieri S; Tumino R; Vineis P; Panico S; van Gils CH; Nøst TH; Sandanger TM; Skeie G; Quirós JR; Agudo A; Sánchez MJ; Amiano P; Huerta JM; Ardanaz E; Schmidt JA; Travis RC; Riboli E; Tsilidis KK; Christakoudi S; Gunter MJ; Rinaldi S
BMC Med; 2019 Sep; 17(1):178. PubMed ID: 31547832
[TBL] [Abstract][Full Text] [Related]
18. Increased Levels of Branched-Chain Amino Acid Associated With Increased Risk of Pancreatic Cancer in a Prospective Case-Control Study of a Large Cohort.
Katagiri R; Goto A; Nakagawa T; Nishiumi S; Kobayashi T; Hidaka A; Budhathoki S; Yamaji T; Sawada N; Shimazu T; Inoue M; Iwasaki M; Yoshida M; Tsugane S
Gastroenterology; 2018 Nov; 155(5):1474-1482.e1. PubMed ID: 30076838
[TBL] [Abstract][Full Text] [Related]
19. Plasma metabolites associated with type 2 diabetes in a Swedish population: a case-control study nested in a prospective cohort.
Shi L; Brunius C; Lehtonen M; Auriola S; Bergdahl IA; Rolandsson O; Hanhineva K; Landberg R
Diabetologia; 2018 Apr; 61(4):849-861. PubMed ID: 29349498
[TBL] [Abstract][Full Text] [Related]
20. Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma.
LaConti JJ; Laiakis EC; Mays AD; Peran I; Kim SE; Shay JW; Riegel AT; Fornace AJ; Wellstein A
BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S1. PubMed ID: 25923219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]